SEARCH RESULTS

11619 RESULTS

Todd E. Golde on Naproxen/Rofecoxib Trial Results Published

COMMENT The study by Aisen et al. shows no benefit to rofecoxib or naproxen in patients with mild to moderate AD. Nevertheless, this negative study is an important contribution to the collective effort to evaluate therapeutic strategies to treat or prevent AD. Th

John Breitner on Naproxen/Rofecoxib Trial Results Published

COMMENT This is the fifth published trial of antiinflammatory treatments for disease modification or symptomatic improvement in Alzheimer's dementia. Two early small studies showed an encouraging suggestion of disease modification (slowing or progression) in

Alexei Koudinov on Naproxen/Rofecoxib Trial Results Published

COMMENT NSAIDS, ALZHEIMER'S DISEASE AND PUBLIC CITIZEN With regard to this news item please see my Open letter to Public Citizen's Health Research Group on Alzheimer's disease research. Science SAGE KE (21 Feb., 2003) [Full Text] ; BMJ (27 Feb., 20

Current Filters

  • TYPE: Comment x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE